The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Mumbai: Haffkine Bio-Pharmaceuticals procurement cell will be seeking explanations from two pharmaceutical firms after it came to light that medicines.

Metformin and lifestyle intervention was associated with delayed type 2 diabetes onset and slower diabetes progression than placebo.

The Food and Drug Administration  has added 10 products to the list of essential medicines exempted from value-added tax  as mandated by law.